ペプチド治療薬の世界市場2020-2026:注射、経口、その他

QYResearchが発行した調査報告書(QYR20AP01775)
◆英語タイトル:Global Peptide Therapeutics Industry Research Report, Growth Trends and Competitive Analysis 2020-2026
◆商品コード:QYR20AP01775
◆発行会社(リサーチ会社):QYResearch
◆発行日:2020年3月(※2024年版があります。お問い合わせください。)
◆ページ数:112
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,900 ⇒換算¥725,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD7,350 ⇒換算¥1,087,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD9,800 ⇒換算¥1,450,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

当リサーチレポートでは、ペプチド治療薬の世界市場規模が2019年xx百万ドルから2026年xx百万ドルまで年平均xx%成長すると予測しています。当レポートは、ペプチド治療薬のグローバル市場動向、メーカー別競争状況、種類別市場規模(注射、経口、その他)、用途別市場規模(がん、代謝障害、中枢神経系、その他)、北米市場、アジア市場、中南米市場、中東・アフリカ市場分析、関連企業情報、サプライチェーン、販売チャネル分析、地域別市場規模予測データなどを掲載しています。

・レポート概要
・グローバル市場動向
・メーカー別競争状況
・ペプチド治療薬の種類別市場2015-2026:注射、経口、その他
・ペプチド治療薬の用途別市場2015-2026:がん、代謝障害、中枢神経系、その他
・ペプチド治療薬の北米市場分析
・ペプチド治療薬のアジア市場分析
・ペプチド治療薬の中南米市場分析
・ペプチド治療薬の中東・アフリカ市場分析
・関連企業情報:Sanofi、Eli Lilly、Novo Nordisk、Takeda、Teva、Novartis、AstraZeneca、Ipsen、AbbVie、Allergan、Ferring、Merck、J & J、The Medicines
・サプライチェーン及び販売チャネル分析
・地域別市場規模予測2021-2026:北米、ヨーロッパ、アジア、中南米、中東・アフリカ
・結論
【レポートの概要】

Peptides are short chains of amino acid monomers linked by peptide (amide) bonds, the covalent chemical bonds formed when the carboxyl group of one amino acid reacts with the amino group of another.North America is the largest consumption place, with a consumption market share nearly 60.9% in 2018. Following North America, Europe is the second largest consumption place with the consumption market share of 21.3%, China and Japan are also an important sales region for the peptide therapeutics.
In 2019, the global Peptide Therapeutics market size was US$ 31680 million and is forecast to US$ 42390 million in 2026, growing at a CAGR of 4.2% from 2020. In this study, 2019 has been considered as the base year and 2020 to 2026 as the forecast period to estimate the market size for Peptide Therapeutics.
The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global Peptide Therapeutics market. The analysts authoring the report have closely studied key strategies adopted by top players of the global Peptide Therapeutics market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global Peptide Therapeutics market. Readers of the report can become informed about current and future trends of the global Peptide Therapeutics market and how they will impact market growth during the forecast period.
Geographic Segmentation
The report offers exhaustive assessment of different region-wise and country-wise Peptide Therapeutics markets such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E etc.
For the period 2015-2026, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global Peptide Therapeutics market. For the period 2015-2020, it provides sales (consumption) analysis and forecast of different regional markets by Application as well as by Type in terms of volume.
Market Segmentation by Type and by Application
The report includes a detailed analysis of leading and by Type and by Application segments of the global Peptide Therapeutics market. All of the segments covered in the report are broadly analyzed based on some deciding factors. The segmental analysis section of the report offers revenue, sales analysis and forecast of the global Peptide Therapeutics market by Type and by Application segment for the period 2015-2026.

Market Segment by Type, the Peptide Therapeutics market is segmented into
Injection
Oral
Other
The proportion of Injection in 2017 is about 74.2%, and the proportion is decreasing trend from 2013 to 2018.

Market Segment by Application, the Peptide Therapeutics market is segmented into
Cancer
Metabolic Disorders
Central Nervous System
Other
The key application of peptide therapeutics is into cancer mainly used for treating prostrate, pancreatic, ovarian, and breast cancer. and the consumption proportion is about 33.6% in 2017.

This report includes the following manufacturers; we can also add the other companies as you want.
Sanofi
Eli Lilly
Novo Nordisk
Takeda
Teva
Novartis
AstraZeneca
Ipsen
AbbVie
Allergan
Ferring
Merck
J & J
The Medicines

The study objectives are:
To analyze and research the global Peptide Therapeutics status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Peptide Therapeutics manufacturers, capacity, production, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Peptide Therapeutics are as follows:
History Year: 2015-2020
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Top Peptide Therapeutics Manufacturers Covered: Ranking by Revenue
1.3 Market Segment by Type
1.3.1 Global Peptide Therapeutics Market Size by Type: 2015 VS 2020 VS 2026 (US$ Million)
1.3.2 Injection
1.3.3 Oral
1.3.4 Other
1.4 Market Segment by Application
1.4.1 Global Peptide Therapeutics Consumption by Application: 2015 VS 2020 VS 2026
1.4.2 Cancer
1.4.3 Metabolic Disorders
1.4.4 Central Nervous System
1.4.5 Other
1.5 Study Objectives
1.6 Years Considered
2 Global Market Perspective
2.1 Global Peptide Therapeutics Revenue (2015-2026)
2.1.1 Global Peptide Therapeutics Revenue (2015-2026)
2.1.2 Global Peptide Therapeutics Sales (2015-2026)
2.2 Peptide Therapeutics Market Size across Key Geographies Worldwide: 2015 VS 2020 VS 2026
2.2.1 Global Peptide Therapeutics Sales by Regions (2015-2020)
2.2.2 Global Peptide Therapeutics Revenue by Regions (2015-2020)
2.3 Global Top Peptide Therapeutics Regions (Countries) Ranking by Market Size
2.4 Peptide Therapeutics Industry Trends
2.4.1 Peptide Therapeutics Market Top Trends
2.4.2 Market Drivers
2.4.3 Peptide Therapeutics Market Challenges
2.4.4 Porter’s Five Forces Analysis
2.4.5 Primary Interviews with Key Peptide Therapeutics Players: Views for Future

3 Competitive Landscape by Manufacturers
3.1 Global Top Peptide Therapeutics Manufacturers by Sales (2015-2020)
3.1.1 Global Peptide Therapeutics Sales by Manufacturers (2015-2020)
3.1.2 Global Peptide Therapeutics Sales Market Share by Manufacturers (2015-2020)
3.1.3 Global 5 and 10 Largest Manufacturers by Peptide Therapeutics Sales in 2019
3.2 Global Top Manufacturers Peptide Therapeutics by Revenue
3.2.1 Global Peptide Therapeutics Revenue by Manufacturers (2015-2020)
3.2.2 Global Peptide Therapeutics Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Peptide Therapeutics Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Peptide Therapeutics as of 2019)
3.4 Global Peptide Therapeutics Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Peptide Therapeutics Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Peptide Therapeutics Market
3.7 Key Manufacturers Peptide Therapeutics Product Offered
3.8 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Peptide Therapeutics Historic Market Review by Type (2015-2020)
4.1.2 Global Peptide Therapeutics Sales Market Share by Type (2015-2020)
4.1.3 Global Peptide Therapeutics Revenue Market Share by Type (2015-2020)
4.1.4 Peptide Therapeutics Price by Type (2015-2020)
4.1 Global Peptide Therapeutics Market Estimates and Forecasts by Type (2021-2026)
4.2.2 Global Peptide Therapeutics Sales Forecast by Type (2021-2026)
4.2.3 Global Peptide Therapeutics Revenue Forecast by Type (2021-2026)
4.2.4 Peptide Therapeutics Price Forecast by Type (2021-2026)

5 Global Peptide Therapeutics Market Size by Application
5.1 Global Peptide Therapeutics Historic Market Review by Application (2015-2020)
5.1.2 Global Peptide Therapeutics Sales Market Share by Application (2015-2020)
5.1.3 Global Peptide Therapeutics Revenue Market Share by Application (2015-2020)
5.1.4 Peptide Therapeutics Price by Application (2015-2020)
5.2 Global Peptide Therapeutics Market Estimates and Forecasts by Application (2021-2026)
5.2.2 Global Peptide Therapeutics Sales Forecast by Application (2021-2026)
5.2.3 Global Peptide Therapeutics Revenue Forecast by Application (2021-2026)
5.2.4 Peptide Therapeutics Price Forecast by Application (2021-2026)

6 North America
6.1 North America Peptide Therapeutics Breakdown Data by Company
6.2 North America Peptide Therapeutics Breakdown Data by Type
6.3 North America Peptide Therapeutics Breakdown Data by Application
6.4 North America Peptide Therapeutics Breakdown Data by Countries
6.4.1 North America Peptide Therapeutics Sales by Countries
6.4.2 North America Peptide Therapeutics Revenue by Countries
6.4.3 U.S.
6.4.4 Canada

7 Europe
7.1 Europe Peptide Therapeutics Breakdown Data by Company
7.2 Europe Peptide Therapeutics Breakdown Data by Type
7.3 Europe Peptide Therapeutics Breakdown Data by Application
7.4 Europe Peptide Therapeutics Breakdown Data by Countries
7.4.1 Europe Peptide Therapeutics Sales by Countries
7.4.2 Europe Peptide Therapeutics Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific Peptide Therapeutics Breakdown Data by Company
8.2 Asia Pacific Peptide Therapeutics Breakdown Data by Type
8.3 Asia Pacific Peptide Therapeutics Breakdown Data by Application
8.4 Asia Pacific Peptide Therapeutics Breakdown Data by Regions
8.4.1 Asia Pacific Peptide Therapeutics Sales by Regions
8.4.2 Asia Pacific Peptide Therapeutics Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam

9 Latin America
9.1 Latin America Peptide Therapeutics Breakdown Data by Company
9.2 Latin America Peptide Therapeutics Breakdown Data by Type
9.3 Latin America Peptide Therapeutics Breakdown Data by Application
9.4 Latin America Peptide Therapeutics Breakdown Data by Countries
9.4.1 Latin America Peptide Therapeutics Sales by Countries
9.4.2 Latin America Peptide Therapeutics Revenue by Countries
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Peptide Therapeutics Breakdown Data by Type
10.2 Middle East and Africa Peptide Therapeutics Breakdown Data by Application
10.3 Middle East and Africa Peptide Therapeutics Breakdown Data by Countries
10.3.1 Middle East and Africa Peptide Therapeutics Sales by Countries
10.3.2 Middle East and Africa Peptide Therapeutics Revenue by Countries
10.3.3 Turkey
10.3.4 Saudi Arabia
10.3.5 U.A.E

11 Company Profiles
11.1 Sanofi
11.1.1 Sanofi Corporation Information
11.1.2 Sanofi Business Overview and Total Revenue (2019 VS 2018)
11.1.3 Sanofi Peptide Therapeutics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.1.4 Sanofi Peptide Therapeutics Products and Services
11.1.5 Sanofi SWOT Analysis
11.1.6 Sanofi Recent Developments
11.2 Eli Lilly
11.2.1 Eli Lilly Corporation Information
11.2.2 Eli Lilly Business Overview and Total Revenue (2019 VS 2018)
11.2.3 Eli Lilly Peptide Therapeutics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.2.4 Eli Lilly Peptide Therapeutics Products and Services
11.2.5 Eli Lilly SWOT Analysis
11.2.6 Eli Lilly Recent Developments
11.3 Novo Nordisk
11.3.1 Novo Nordisk Corporation Information
11.3.2 Novo Nordisk Business Overview and Total Revenue (2019 VS 2018)
11.3.3 Novo Nordisk Peptide Therapeutics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.3.4 Novo Nordisk Peptide Therapeutics Products and Services
11.3.5 Novo Nordisk SWOT Analysis
11.3.6 Novo Nordisk Recent Developments
11.4 Takeda
11.4.1 Takeda Corporation Information
11.4.2 Takeda Business Overview and Total Revenue (2019 VS 2018)
11.4.3 Takeda Peptide Therapeutics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.4.4 Takeda Peptide Therapeutics Products and Services
11.4.5 Takeda SWOT Analysis
11.4.6 Takeda Recent Developments
11.5 Teva
11.5.1 Teva Corporation Information
11.5.2 Teva Business Overview and Total Revenue (2019 VS 2018)
11.5.3 Teva Peptide Therapeutics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.5.4 Teva Peptide Therapeutics Products and Services
11.5.5 Teva SWOT Analysis
11.5.6 Teva Recent Developments
11.6 Novartis
11.6.1 Novartis Corporation Information
11.6.2 Novartis Business Overview and Total Revenue (2019 VS 2018)
11.6.3 Novartis Peptide Therapeutics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.6.4 Novartis Peptide Therapeutics Products and Services
11.6.5 Novartis SWOT Analysis
11.6.6 Novartis Recent Developments
11.7 AstraZeneca
11.7.1 AstraZeneca Corporation Information
11.7.2 AstraZeneca Business Overview and Total Revenue (2019 VS 2018)
11.7.3 AstraZeneca Peptide Therapeutics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.7.4 AstraZeneca Peptide Therapeutics Products and Services
11.7.5 AstraZeneca SWOT Analysis
11.7.6 AstraZeneca Recent Developments
11.8 Ipsen
11.8.1 Ipsen Corporation Information
11.8.2 Ipsen Business Overview and Total Revenue (2019 VS 2018)
11.8.3 Ipsen Peptide Therapeutics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.8.4 Ipsen Peptide Therapeutics Products and Services
11.8.5 Ipsen SWOT Analysis
11.8.6 Ipsen Recent Developments
11.9 AbbVie
11.9.1 AbbVie Corporation Information
11.9.2 AbbVie Business Overview and Total Revenue (2019 VS 2018)
11.9.3 AbbVie Peptide Therapeutics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.9.4 AbbVie Peptide Therapeutics Products and Services
11.9.5 AbbVie SWOT Analysis
11.9.6 AbbVie Recent Developments
11.10 Allergan
11.10.1 Allergan Corporation Information
11.10.2 Allergan Business Overview and Total Revenue (2019 VS 2018)
11.10.3 Allergan Peptide Therapeutics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.10.4 Allergan Peptide Therapeutics Products and Services
11.10.5 Allergan SWOT Analysis
11.10.6 Allergan Recent Developments
11.11 Ferring
11.11.1 Ferring Corporation Information
11.11.2 Ferring Business Overview and Total Revenue (2019 VS 2018)
11.11.3 Ferring Peptide Therapeutics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.11.4 Ferring Peptide Therapeutics Products and Services
11.11.5 Ferring SWOT Analysis
11.11.6 Ferring Recent Developments
11.12 Merck
11.12.1 Merck Corporation Information
11.12.2 Merck Business Overview and Total Revenue (2019 VS 2018)
11.12.3 Merck Peptide Therapeutics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.12.4 Merck Peptide Therapeutics Products and Services
11.12.5 Merck SWOT Analysis
11.12.6 Merck Recent Developments
11.13 J & J
11.13.1 J & J Corporation Information
11.13.2 J & J Business Overview and Total Revenue (2019 VS 2018)
11.13.3 J & J Peptide Therapeutics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.13.4 J & J Peptide Therapeutics Products and Services
11.13.5 J & J SWOT Analysis
11.13.6 J & J Recent Developments
11.14 The Medicines
11.14.1 The Medicines Corporation Information
11.14.2 The Medicines Business Overview and Total Revenue (2019 VS 2018)
11.14.3 The Medicines Peptide Therapeutics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.14.4 The Medicines Peptide Therapeutics Products and Services
11.14.5 The Medicines SWOT Analysis
11.14.6 The Medicines Recent Developments

12 Supply Chain and Sales Channels Analysis
12.1 Supply Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Peptide Therapeutics Sales Channels
12.2.2 Peptide Therapeutics Distributors
12.3 Peptide Therapeutics Customers

13 Estimates and Projections by Regions (2021-2026)
13.1 Global Peptide Therapeutics Sales Forecast (2021-2026)
13.1.1 Global Peptide Therapeutics Sales Forecast by Regions (2021-2026)
13.1.2 Global Peptide Therapeutics Revenue Forecast by Regions (2021-2026)
13.2 North America Market Size Forecast (2021-2026)
13.2.1 North America Peptide Therapeutics Sales Forecast (2021-2026)
13.2.2 North America Peptide Therapeutics Revenue Forecast (2021-2026)
13.2.3 North America Peptide Therapeutics Size Forecast by County (2021-2026)
13.3 Europe Market Size Forecast (2021-2026)
13.3.1 Europe Peptide Therapeutics Sales Forecast (2021-2026)
13.3.2 Europe Peptide Therapeutics Revenue Forecast (2021-2026)
13.3.3 Europe Peptide Therapeutics Size Forecast by County (2021-2026)
13.4 Asia Pacific Market Size Forecast (2021-2026)
13.4.1 Asia Pacific Peptide Therapeutics Sales Forecast (2021-2026)
13.4.2 Asia Pacific Peptide Therapeutics Revenue Forecast (2021-2026)
13.4.3 Asia Pacific Peptide Therapeutics Size Forecast by Region (2021-2026)
13.5 Latin America Market Size Forecast (2021-2026)
13.5.1 Latin America Peptide Therapeutics Sales Forecast (2021-2026)
13.5.2 Latin America Peptide Therapeutics Revenue Forecast (2021-2026)
13.5.3 Latin America Peptide Therapeutics Size Forecast by County (2021-2026)
13.6 Middle East and Africa Market Forecast
13.6.1 Middle East and Africa Peptide Therapeutics Sales Forecast (2021-2026)
13.6.2 Middle East and Africa Peptide Therapeutics Revenue Forecast (2021-2026)
13.6.3 Middle East and Africa Peptide Therapeutics Size Forecast by County (2021-2026)

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

...

【掲載企業】

Sanofi、Eli Lilly、Novo Nordisk、Takeda、Teva、Novartis、AstraZeneca、Ipsen、AbbVie、Allergan、Ferring、Merck、J & J、The Medicines

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ ペプチド治療薬の世界市場2020-2026:注射、経口、その他(Global Peptide Therapeutics Industry Research Report, Growth Trends and Competitive Analysis 2020-2026)]についてメールでお問い合わせはこちらでお願いします。